Related Experiment Videos
Second-generation dimeric inhibitors of chitin synthase
Adam R Yeager1, Nathaniel S Finney
1University of California, San Diego, Department of Chemistry and Biochemistry, 9500 Gilman Dr., La Jolla, CA 92093-0358, USA.
Bioorganic & Medicinal Chemistry
|November 24, 2004
Summary
Researchers developed novel uridine dimers as potential inhibitors of fungal chitin synthase (CS), a key target for antifungal drugs. These compounds mimic pyrophosphate, offering a new strategy for antifungal drug development.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Mycology
Background:
- Chitin synthase (CS) is a crucial enzyme for fungal cell wall integrity.
- CS is a validated and attractive target for developing new antifungal medications.
- Existing antifungal therapies face challenges like resistance and toxicity.
Purpose of the Study:
- To present expanded results on the development of mechanism-based inhibitors of fungal CS.
- To explore novel chemical scaffolds as potential CS inhibitors.
- To identify compounds that mimic the pyrophosphate transition state of CS.
Main Methods:
- Design and synthesis of uridine dimers linked by tartrate amide functionalities.
- Biochemical assays to evaluate the inhibitory activity of synthesized compounds against CS.
- Structure-activity relationship (SAR) studies to optimize inhibitor potency.
Main Results:
- Successfully synthesized a series of uridine dimers linked by tartrate amides.
- Identified specific compounds exhibiting potent inhibition of fungal CS.
- Demonstrated that these compounds act as pyrophosphate mimics, binding to the CS active site.
Conclusions:
- Uridine dimers linked by tartrate amides represent a promising new class of mechanism-based CS inhibitors.
- These compounds show potential for development into novel antifungal agents.
- The pyrophosphate mimic strategy provides a viable approach for targeting CS.